Antihypertensive Drugs in the Stroke-Prone Spontaneously Hypertensive Rat

References

• Okamoto K, Yamori Y, Nagaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 1974; 34–35(Suppl.1)1143–153
   Google Scholar
• Tagami M, Nara Y, Kubota A, Sunaga T, Maezawa H, Fujino H, Yamori Y. Ultrastructural characteristics of occluded perforating arteries in stroke-prone spontaneously hypertensive rats. Stroke 1987; 18: 733–740
   PubMed Web of Science ®Google Scholar
• Ogata J, Fujishima M, Tamaki K, Nakatomi Y, Ishitsuka T, Omae T. Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. I. A light- and electron-microscopic study of the brain. Acta Neuropathol. 1980; 51: 179–184
   PubMed Web of Science ®Google Scholar
• Baumbach G L., Dobrin P. B., Hart M. N., Heistad D. D. Mechanics of cerebral arterioles in hypertensive rats. Circ Res. 1988; 62: 56–64
   PubMed Web of Science ®Google Scholar
• Smeda J S. Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol. 1992; 70: 552–564
   PubMed Web of Science ®Google Scholar
• Mayhan W. G., Faraci F. M. Cerebral vasconstrictor responses to serotonin during chronic hypertension. Hypertension 1990; 15: 872–876
   PubMed Web of Science ®Google Scholar
• Shibota M, Nagaoka A, Shino A, Fujita T. Renin-angiotensin system in stroke-prone spontaneously hypertensive rats. Am J Physiol. 1979; 236: H409–416
   PubMed Web of Science ®Google Scholar
• Volpe M, Camargo M. J.F., Mueller F. B., Campbell W. G., Sealey J. E., Pecker M. S., Sosa R. E., Laragh J. H. Relation of plasma renin to end organ damage and to protection of K+ feeding in stroke-prone hypertensive rats. Hypertension 1990; 15: 318–326
   PubMed Web of Science ®Google Scholar
• Yamori Y, Horie R, Tanase H, Fujiwara K, Nara Y, Lovenberg W. Possible role of nutritional factors in the incidence of cerebral lesions in stroke-prone spontaneously hypertensive rats. Hypertension 1984; 6: 49–53
   PubMed Web of Science ®Google Scholar
• Horie R, Yamori Y., Nara Y., Sawamura M., Mizushima S. Aggravating effects of isolated caging n the development of hypertension and its complications in stroke-prone spontaneously hypertensive rats (SHR-SP) and Wistar-Kyoto rats (WKY). Clin Exp Hypertens. 1991; A13: 859–864
   Google Scholar
• Mulvany M J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977; 41: 19–26
   PubMed Web of Science ®Google Scholar
• Fornes P, Richer C, Vacher E, Bruneval P, Giudicelli J F. Losartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharmacol. 1993; 22: 305–313
   PubMed Web of Science ®Google Scholar
• Vacher E, Fornes P, Domergue V, Richer C, Bruneval P, Giudicelli J F. Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am J Hypertens. 1993; 6: 951–959
   PubMed Web of Science ®Google Scholar
• Richer C, Fornes P, Vacher E, Bruneval P, Giudicelli J F. Trandolapril's protective effects in stroke-prone spontaneously hypertensive rats persist after treatment withdrawal. Am J Cardiol. 1994; 73: 26C–35C
   PubMed Web of Science ®Google Scholar
• Vacher E., Richer C., Fornes P., Clozel J. P., Giudicelli J. F. Mibefradil, a selective calcium T-channel blocker, in the stroke-sprone spontaneously hypertensive rat. J Cardiovasc Pharmacol. 1996; 27: 686–694
   PubMed Web of Science ®Google Scholar
• Vacher E., Richer C., Giudicelli J. F. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats. J Hypertens 1996, in press.
   PubMedGoogle Scholar
• Stier C. T., Chander P. N., Gutstein W. H., Levine S, Itskovitz H. D. Therapeutic benefit of captopril in salt-loaded stroke-prone spontaneously hypertensive rats is independent of hypotensive effect. Am J Hypertens. 1991; 4: 680–687
   PubMed Web of Science ®Google Scholar
• Stier C T., Benter I. F., Ahmad S, Zuo H, Selig N, Roethel S, Levine S, Itskovitz H. D. Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 1989; 13: 115–121
   PubMed Web of Science ®Google Scholar
• Hajdu M. A., Heistad D. D., Baumbach G. L. Effects of antihypertensive therapy on mechanics of cerebral arterioles in rats. Hypertension 1991; 17: 308–316
   PubMed Web of Science ®Google Scholar
• Camargo M. J.F., Von Lutterotti N, Pecker M. S., James G. D., Timmermans P. B.M.W.M., Laragh J. H. DuP 753 increases survival in spontaneously hypertensive stroke-prone rats fed a high sodium diet. Am J Hypertens. 1991; 4: S341–345
   PubMed Web of Science ®Google Scholar
• Gries J, Kretzschmar R, Neumann B W. Development of hypertension and life span in stroke-prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. J Cardiovasc Pharmacol. 1989; 13(Suppl.4)S79–89
   PubMedGoogle Scholar
• Nayler W. G. Vascular injury: mechanisms and manifestations. Am J Med. 1991; 90(Suppl.4B)8S–13S
   Google Scholar
• Takakura S, Furuichi Y, Yamamoto T, Ogawa T, Satoh H, Mori J. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats. Stroke 1994; 25: 677–683
   PubMed Web of Science ®Google Scholar
• Smeda J. S., Tkachenko O. Effects of diuretics on stroke development in Kyoto-Wistar stroke-prone spontaneously hypertensive rats. Clin Sci. 1991; 81: 335–340
   PubMed Web of Science ®Google Scholar
• Ruchoux M. M., Bakri F., Bosquet D., Droy M. T., Guillemain J., Lhuintre Y. Comparaison des effets du ciclétanine et du captopril sur les lésions rénales et cardiaques du rat spontanément hypertendu (SHR-SP). Arch Mal Coeur 1989; 82: 169–174
   PubMedGoogle Scholar
• Miyagishi A., Maniwa T., Noguchi T., Hara Y. Prevention of cerebral stroke by arotinolol in salt-loaded SHR-SP. Clin Exp Hypertens. 1991; A13: 1077–1089
   Google Scholar
• Vacher E., Richer C., Cazaubon C., Fornes P., Nisato D., Giudicelli J. F. Are vasopressin peripheral V1 receptors involved in the development of malignant hypertension and stroke in SHR-SPs. Fundam Clin Pharmacol. 1995; 9: 469–478
   PubMed Web of Science ®Google Scholar
• Stier C. T., Adler L. A., Levine S., Chander P. N. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats. J Hypertens. 1993; 11(Suppl.3)S37–S42
   Google Scholar
• Stier C. T., Benter I. F., Levine S. Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats. Stroke 1988; 19: 1145–1150
   PubMed Web of Science ®Google Scholar
• Yamori Y., Horie R. Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 1977; 8: 456–461
   PubMed Web of Science ®Google Scholar
• Kazda S., Grunt M., Hirth C., Preis W., Stasch J. P. Calcium antagonism and protection of tissues from calcium damage. J Hypertens. 1987; 5(Suppl.4)S37–S42
   Web of Science ®Google Scholar
• Lens L., Luckhaus G., Stasch J. P., Kazda S. Therapy of diseased stroke-prone spontaneously hypertensive rats with nimodipine. Stroke 1990; 21(Suppl.IV)IV111–IV112
   Google Scholar
• Shinyama H, Nagai H, Kawamura T, Narita Y, Uchida T, Watanabe M, Kagitani Y. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats. J Pharmacol Exp Ther. 1995; 272: 911–919
   PubMed Web of Science ®Google Scholar
• Contard F, Sabri A, Glukhova M, Sartore S, Marotte F, Pomies J P, Schiavi P, Guez D, Samuel J. L., Rappaport L. Arterial smooth muscle cell phenotype in stroke-prone spontaneously hypertensive rats. Hypertension 1993; 22: 665–676
   PubMed Web of Science ®Google Scholar
• Robertson A L, Khairallah P. A. Arterial endothelial permeability and vascular disease: the “trap door” effect. Exp Mol Pathol. 1973; 18: 241–260
   PubMed Web of Science ®Google Scholar
• Hajdu M A, Baumbach G. L. Mechanics of large and small cerebral arteries in chronic hypertension. Am J Physiol. 1994; 266: H1027–H1033
   PubMed Web of Science ®Google Scholar
• Stier C. T., Sim J., Mahboubi K., Shen W., Levine S., Chander P. N. Prevention of stroke and hypertensive renal disease by the angiotensin II receptor antagonist DUP 753 in salt-loaded stroke-prone SHR. Current advances in ACE inhibition, G. A. McGregor, P. Sever. Churchill Livingstone Publ., London 1991; 252–255
   Google Scholar